Advertisements

InspireMD Inc. (NSPR) Stock Quote

Detailed Quote for InspireMD Inc. (NSPR)
$ 0.137   -0.008 (-5.52%) Volume: 4.89m 4:00 PM EST Dec 15, 2017
After Hours:  $ 0.1422   0.0052 (+3.80%) Volume: 79.41k 7:56 PM EST Dec 15, 2017
Today 5d 1m 3m 1y more
Last Price
0.137
Change $
0.008
Change %
5.52%
Tick
  
Bid
0.1341
Bid Size
1,000
Ask
0.14
Ask Size
102,200
Open
0.1371
High
0.148
Low
0.13411
Prev Close
0.145
Last Trade
12/15/17
Volume
4.89m
52 Wk Hi
3.97000002
52 Wk Low
0.125
Market Cap
1.02m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
7,465,889
EPS (TTM)
-1.15999996
PE Ratio
N/A
Exchange
NYSE American
News and Media for InspireMD Inc. (NSPR)
Sector News | Topic News
News for InspireMD Inc. (NSPR)
Thu, Dec 07, 2017
12:23 PM InspireMD's CGuard EPS Demonstrates Improved Outcomes over Carotid Endarterectomy in 50 Patient Comparative Study; Preliminary Results Featured at the 7th Munich Vascular Conference 2017 - GlobeNewswire
Tue, Dec 05, 2017
1:27 PM InspireMD's CGuard EPS shows durable effect in study - SeekingAlpha
1:00 PM InspireMD Announces Preliminary 2 Year Follow-up Results from the PARADIGM Clinical Study Using CGuard(TM) EPS - GlobeNewswire
Wed, Nov 29, 2017
7:00 AM InspireMD Announces Planned Recapitalization - Marketwired
7:00 AM InspireMD Announces Planned Recapitalization - Marketwired
Wed, Nov 08, 2017
9:32 AM InspireMD's (NSPR) CEO Jim Barry on Q3 2017 Results - Earnings Call Transcript - SeekingAlpha
Tue, Nov 07, 2017
11:55 PM InspireMD reports Q3 results - SeekingAlpha
4:05 PM InspireMD Announces Third Quarter 2017 Results; CGuard(TM) Revenue Increases 90% Versus Same Period Last Year - Marketwired
4:05 PM InspireMD Announces Third Quarter 2017 Results; CGuard(TM) Revenue Increases 90% Versus Same Period Last Year - Marketwired
Wed, Nov 01, 2017
7:30 AM InspireMD Schedules Third Quarter 2017 Earnings Conference Call - Marketwired
7:30 AM InspireMD Schedules Third Quarter 2017 Earnings Conference Call - Marketwired
Wed, Oct 25, 2017
7:30 AM InspireMD's CGuard(TM) Carotid Embolic Prevention System Featured in Live Case at Cracow Vascular Summit 2017 in Poland - Marketwired
7:30 AM InspireMD's CGuard(TM) Carotid Embolic Prevention System Featured in Live Case at Cracow Vascular Summit 2017 in Poland - Marketwired
Tue, Oct 24, 2017
9:47 AM New York Stock Exchange Accepts InspireMD's Plan to Regain Compliance - Marketwired
9:47 AM New York Stock Exchange Accepts InspireMD's Plan to Regain Compliance - Marketwired
Thu, Oct 12, 2017
10:36 AM InspireMD Announces Distribution Agreement for MGuard Prime(TM) in Chile - Marketwired
10:36 AM InspireMD Announces Distribution Agreement for MGuard Prime(TM) in Chile - Marketwired
Mon, Oct 09, 2017
3:33 PM Study commences in Russia comparing InspireMD's CGuard to Abbott's RX Acculink; shares up 19% - SeekingAlpha
11:08 AM InspireMD Announces the Start of Patient Enrollment in an Investigator Initiated Trial of CGuard(TM) EPS in Russia - Marketwired
11:08 AM InspireMD Announces the Start of Patient Enrollment in an Investigator Initiated Trial of CGuard(TM) EPS in Russia - Marketwired
More News for NSPR >>

Tags for InspireMD Inc.

Research stocks or mutual funds related to InspireMD Inc. by keywords or tags. Find companies that have a similar focus to NSPR. The keywords below have been associated to NSPR by either user submission or electronic means.